Viatris Announces Approval of WAKIX® (Pitolisant) in Japan

Viatris · Product launch · September 16, 2026

Japan's Ministry of Health, Labour and Welfare approved WAKIX for treating narcolepsy and excessive daytime sleepiness related to obstructive sleep apnea syndrome. It is the first histamine H3 receptor antagonist approved in Japan for these conditions.

Read the announcement

AntSpace’s summary of Viatris’s own announcement: read the original.

More updates from Viatris